To emphasise the need to treat heart attacks within the ‘Golden Hour’
Investment to help build Concord Biotech into an integrated biopharma company focused on high growth niche therapies
The study addresses the persistence of latent HIV reservoirs in patients who are on therapy
Easterbrook will provide technical information, training and support
Incidences of the disease are set to increase to over 410,000 by 2024 across US, France, Germany, Italy, Spain, the…
The conference on August 5 and 6, 2016 is likely to see more than 4500 visitors
To be among the top three pharma markets by incremental growth
Sameer Walia, Managing Director, The Smart Cube examines the potential implications of Brexit on the overall pharma industry in India…
The strong market growth will be driven by the predicted emergence of targeted therapies for bladder cancer and increasing prostate…
The facility manufactures active pharmaceutical ingredients
The oral dosage facility in Bengaluru is now US FDA compliant
GlobalData forecasts that GSK’s MenABCWY vaccine will have sales of just under $437 million in 2025 A vaccine protecting against…
There is further evidence of potential benefit in rare blood cancers; regulatory submissions for advanced SM and acute myeloid leukemia…
Ties up with Italy-based Labo Cosprophar, to launch two new products for hair & skin care RPG Life Sciences has…
Receives product patents from Europe and Eurasia
Javin Bhinde, MD & CEO, SynCore Consulting shares details of the PatientSafe India conference this year and its objectives. He…
FOG 27 closure can be opened in about a third of the time – and with 70 per cent less…
Sanofi’s animal health business will go to Boehringer Ingelheim while the latter’s consumer healthcare business will be integrated with the…
